Arterial Blood Gas Kits Market Market is surging with CAGR of 7.8% from 2020 to 2028

 

According to our new research study on “Arterial Blood Gas Kits Market Forecast to 2028 – COVID-19 Impact and Global Analysis – by product type, end-user,” the market is expected to reach US$ 773.01 million in 2028 from US$ 455.84 million in 2021 growing at a CAGR of 7.8% from 2021-2028. An arterial blood gas (ABG) is a blood test carried out by taking blood from an artery, rather than a vein. It is performed so that an accurate measurement of oxygen and carbon dioxide levels can be obtained, which then allows the patients oxygen to be delivered appropriately. The kit includes a needle protection sheath that cores the bevel and encapsulates the contaminated needle to prevent blood spatter. The integral safety clips on the syringe allows for audible and visual confirmation that the needle is secure. Syringes are available non-vented or with a rear vented system which automatically evacuates air out the back of the syringe as the blood fills during the draw. Arterial blood gas tests are also performed on patients in respiratory distress, such as an asthma attack.

 

Arterial Blood Sampling syringes utilize lithium heparin with a concentration of 23.5 I.U. per mL. The specially formulated dry lithium heparin provides the necessary anticoagulation along with minimal interference for more accurate and consistent results. The syringes are available with a broad choice of product features. There are various types of 1 ml syringe volume which has different features. For instance, Thermo Fishers Smiths Medical Pro-Vent Plus provides arterial Blood Sampling syringes utilize dry lithium heparin with a low concentration of 7 I.U. per mL. The low heparin concentration allows for healthcare professionals to obtain very small blood samples and still maintain the full range of blood gas, electrolyte, and metabolite testing with reduced heparin interference and extended clotting time.

 

Becton Dickinson and Company, Radiometer Medical ApS, Smiths Medical, Vyaire Medical, Opti Medical Systems, Inc., Westmed Medical, Siemens Healthineers AG, ITL Biomedical, i-SENS, Inc., and Teleflex Incorporated amongst others. The companies are adopting inorganic and organic growth strategies to expand their global footprints and product portfolio to meet the rising demands for the Arterial Blood Gas Kits. For instance, in Jan 2020, Siemens Healthineers has received U.S. Food and Drug Administration approval for RAPIDPoint 500e Blood Gas System. RAPIDLyte Arterial Sampling Syringes and RAPIDLyte Multicap Capillaries offered by the Siemens are compatible to use with RAPIDPoint 500e Blood Gas System. This product approval will strengthen the market position of the company.

Huge population suffers from the various types of respiratory diseases across the world. Smoking, infections, and genetic factors can cause respiratory diseases. Chronic obstructive pulmonary disease (COPD), asthma, and pneumonia are a few medical conditions exerting a huge burden on the public healthcare system in various countries worldwide. The American Lung Association reported that COPD is the third leading cause of death in the US, where over 16.4 million people are diagnosed with the condition. Further, according to the US Department of Health and Human Services, around 25 million people in the US had asthma in 2019, which is one of the most common respiratory diseases in the world. Further, as per the World Health Organization (WHO), globally pneumonia accounted for 15% of the total deaths of children below the age of 5 years in 2017, which reported the deaths of 808,694 children. Patients suffering from the respiratory disorders usually experience trouble in breathing and oxygen shortage. Arterial blood gas (ABG) test is carried out to measure the amount of oxygen and carbon dioxide dissolved in arterial blood. The test helps in delivering care to patients suffering from acute and chronic respiratory disease. Thus, the growing prevalence of acute and chronic respiratory diseases propels the demand for arterial blood gas kits.